CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutation
Crossref DOI link: https://doi.org/10.1007/s12020-015-0717-4
Published Online: 2015-08-19
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fallahi, Poupak
Ferrari, Silvia Martina
La Motta, Concettina
Materazzi, Gabriele
Bocci, Guido
Da Settimo, Federico
Miccoli, Paolo
Antonelli, Alessandro
Text and Data Mining valid from 2015-08-19